Searched for
STRIDES PHARMA NEWS
Strides Pharma Science shares jump 9% after USFDA EIR for Bengaluru facilityStrides Pharma Science shares rise sharply on Thursday after the USFDA issued an Establishment Inspection Report (EIR) for its Bengaluru fa...- Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...
- Stock Radar: Strides Pharma breaks out from 7-month consolidation to hit fresh 52-week high; time to buy?Strides Pharma Science stock shows positive movement. It broke a seven-month consolidation phase. Experts suggest a buy with a target of Rs...
- Stock Radar: This pharma stock sees mild consolidation after 130% rally in 1 year; time to buy the dip?The pharma stock is a part of the S&P BSE Smallcap index. It saw an uptrend, rising from Rs 393 as of June 9, 2023, to Rs 901 recorded on J...
- Buy Strides Pharma Science, target price Rs 630: Prabhudas LilladherPromoters held 28.07 per cent stake in the company as of 30-Jun-2023, while FIIs owned 16.72 per cent, DIIs 19.59 per cent.
- Reduce Strides Pharma Science, target price Rs 495: ICICI SecuritiesStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 4766.18 Crore) operating in Pha...
- Buy Strides Pharma Science, target price Rs 500: ICICI SecuritiesStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 3085.64 Crore) operating in Pha...
- Buy Strides Pharma Science, target price Rs 402: ICICI SecuritiesStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 3026.83 Crore) operating in Pha...
- Accumulate Strides Pharma Science, target price Rs 355: GeojitStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 2836.92 Crore) operating in Pha...
- Buy Strides Pharma Science, target price Rs 355: EdelweissStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 2914.80 Crore) operating in Pha...
- Sell Strides Pharma, target Rs 375: Manas JaiswalSell Strides Pharma at a price target of Rs 375 and a stoploss at Rs 406.
- Sell Strides Pharma Science, target Rs 400: Kunal BothraSell Strides Pharma Science Ltd. at a price target of Rs 400.0 and a stoploss at Rs 420 from entry point.
- Strides Pharma drops 3% on USFDA observation for Bengaluru plantThe observations are not material in nature, the company said.
- Pharma looks best export theme, valuations attractive: Deepak ShenoyFDA plant warnings have increased of late; Trans-Pacific Partnership has reduced pharma companies' access to some pacific countries, says S...
- Smaller names in pharma space may have good strides: Prakash Diwan"There is lot of news flow driven moves that you continuously see in this space"
- Strides Arcolab set to acquire Shasun Pharma in an all-stock dealShareholders of Chennai-based Shasun Pharma will receive five equity shares of Strides for every 16 equity shares they hold in the company.
- Strides Arcolabs' Agila Specialties Pharma Corporation forms JV with Jamp PharmaStrides Arcolabs' injectable drug division Agila Specialties Pharma Corporation has formed a 70:30 JV with Jamp Pharma to introduce injecta...
- Buy Strides Arcolab from a long term perspective: Sonam Udasi"If you have a long term, go for stocks like Strides Arcolab even Aurobindo Pharma after that huge correction we saw."
- Accumulate Strides Arcolab on every dip: Ashit SuriAshit Suri, Fundamental Research Analyst, JV Capital Services in an interview with ET Now talks about his pick from the pharma stocks.
- Pharma stocks to do well in 2010: JV Capital ServicesSajiv Dhawan, MD, JV Capital Services, in a chat with ET Now talks about pharma and fertiliser space
Load More
